NEWS & INSIGHTS

Latest News
Exscientia and Blue Oak Pharmaceuticals announce collaboration to rapidly discover innovative treatments for CNS disorders
Read Now

All

Exscientia and Blue Oak Pharmaceuticals announce collaboration to rapidly discover innovative treatments for CNS disorders

READ MORE

Exscientia appoints industry R&D veteran, David Nicholson, as Chairman as company extends pipeline

READ MORE

Huadong Medicine and Exscientia enter co-development partnership to accelerate oncology drug discovery through artificial intelligence

READ MORE

Exscientia Featured in TECH TRACK 100 report on Britain's Fastest Growing Tech Companies

READ MORE

Europe’s Largest Initiative Launches to Accelerate Therapy Development for COVID-19 and Future Coronavirus Threats

READ MORE

Exscientia raises $60 million in Series C financing round led by Novo Holdings

READ MORE

SRI International and Exscientia Enter Collaboration to Accelerate Drug Discovery Through Automation and Artificial Intelligence

READ MORE

Exscientia announces joint initiative to identify COVID-19 drugs with Diamond Light Source and Scripps Research

READ MORE

The Guardian focuses on Exscientia's screen of 15,000 drugs in search for a coronavirus treatment

READ MORE
  • <<
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • >>